RT @Lymphoma_Papers: Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analy…
RT @Lymphoma_Papers: Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analy…
RT @MarceloBellesso: Attractive paper about CNS prophylaxis A) similar points such as other papers - 1) retrospective non-randomized - 2)…
Attractive paper about CNS prophylaxis A) similar points such as other papers - 1) retrospective non-randomized - 2) early CNS relapses within 1 year B) different point - 1) B2MG > 4mcg/mL independent risk for CNS relapses.
RT @Lymphoma_Papers: Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analy…
Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analysis. #lymphoma #lymsm https://t.co/wZBEpV3VHZ